Talk to the Institute
Published mark

Biogen

BIOGEN INC.

NASDAQ: BIIB. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:a2b92c4d-4ab5-4d97-bea2-91da927acb21
SEC CIK
0000875045
Website
www.biogen.com Open
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 24, 2026
Newest evidence
May 3, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Christopher A. ViehbacherPresident and Chief Executive Officer
Chair
Not published
Independent
Not published
Published claims
385 distinct sources
Evidence records
180 pinned
Source conflicts
0None open

Built from 5 distinct sources and 18 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

EXECUTIVE APPOINTED

Adam Keeney executive of Biogen, effective 2026-02-06.

EffectiveEffective Feb 6, 2026E3

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
Executive Vice President, Head of Corporate DevelopmentAdam KeeneyFeb 2026currentSource reportedE3
Executive Vice President and Chief Human Resources OfficerGinger GregoryFeb 2026currentSource reportedE7
Executive Vice President, Head of ResearchJane GroganFeb 2026currentSource reportedE8
Executive Vice President, Pharmaceutical Operations and TechnologyNicole MurphyFeb 2026currentSource reportedE10
Executive Vice President, Head of DevelopmentPriya SinghalFeb 2026currentSource reportedE11
Executive Vice President, Global Product Strategy and CommercializationRachid IzzarFeb 2026currentSource reportedE13
Executive Vice President and Chief Financial OfficerRonald J. KramerFeb 2026currentSource reportedE14
Vice President, Chief Accounting Officer and Global Corporate ControllerSean GodboutFeb 2026currentSource reportedE15
Executive Vice President, Chief Legal OfficerSusan H. AlexanderFeb 2026currentSource reportedE16
Executive Vice President, Head of Corporate DevelopmentAndrs Conesa Ph.DNot capturedunknownSource reportedE4
President and Chief Executive OfficerChristopher A. ViehbacherNot capturedunknownSource reportedE5
Executive Vice President and Chief Human Resources OfficerGeorge Mclean Milne Jr., Ph.D.Not capturedunknownSource reportedE6
Executive Vice President, Head of ResearchJane Grogan, Ph.D.Not capturedunknownSource reportedE9
Executive Vice President, Head of DevelopmentPriya Singhal, M.D., M.P.H.Not capturedunknownSource reportedE12

Board of directors

Evidence
DirectorStatusSinceCommitteesClaim
Eric K. RowinskyIndependence not publishedNot publishedCompensation and Management DevelopmentCorporate GovernanceSource reportedE17
Jesus B. MantasIndependence not publishedNot publishedCompensation and Management DevelopmentSource reportedE17
Lloyd MinorIndependence not publishedNot publishedAuditSource reportedE17
Maria C. FreireIndependence not publishedNot publishedCompensation and Management DevelopmentCorporate GovernanceSource reportedE17
Menelas PangalosIndependence not publishedNot publishedCompensation and Management DevelopmentSource reportedE17
Monish PatolawalaIndependence not publishedNot publishedAuditSource reportedE17
Stephen A. SherwinIndependence not publishedNot publishedAuditSource reportedE17
Susan K. LangerIndependence not publishedNot publishedCompensation and Management DevelopmentSource reportedE17
William A. HawkinsIndependence not publishedNot publishedAudit, chairCorporate GovernanceSource reportedE17

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
AuditWilliam A. HawkinsWilliam A. Hawkins, Lloyd Minor, Monish Patolawala, Stephen A. SherwinNot described in the published record
Compensation and Management DevelopmentNot publishedEric K. Rowinsky, Jesus B. Mantas, Maria C. Freire, Menelas Pangalos, Susan K. LangerNot described in the published record
Corporate GovernanceNot publishedEric K. Rowinsky, Maria C. Freire, William A. HawkinsNot described in the published record
Committee AppointmentWilliam A. Hawkins: chair, Audit
Source reportedE17
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:committee_appointment:24
Committee AppointmentLloyd Minor: member, Audit
Source reportedE17
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:committee_appointment:25
Committee AppointmentMonish Patolawala: member, Audit
Source reportedE17
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:committee_appointment:26
Committee AppointmentStephen A. Sherwin: member, Audit
Source reportedE17
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:committee_appointment:27
Committee AppointmentEric K. Rowinsky: member, Compensation and Management Development
Source reportedE17
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:committee_appointment:29
Committee AppointmentJesus B. Mantas: member, Compensation and Management Development
Source reportedE17
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:committee_appointment:30
Committee AppointmentMaria C. Freire: member, Compensation and Management Development
Source reportedE17
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:committee_appointment:31
Committee AppointmentMenelas Pangalos: member, Compensation and Management Development
Source reportedE17
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:committee_appointment:32
Committee AppointmentSusan K. Langer: member, Compensation and Management Development
Source reportedE17
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:committee_appointment:33
Committee RecordCorporate Governance: Chair not stated; Members Eric K. Rowinsky; Maria C. Freire; William A. Hawkins
Source reportedE17
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:committee_record:34
Committee AppointmentEric K. Rowinsky: member, Corporate Governance
Source reportedE17
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:committee_appointment:35
Committee AppointmentMaria C. Freire: member, Corporate Governance
Source reportedE17
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:committee_appointment:36
Committee AppointmentWilliam A. Hawkins: member, Corporate Governance
Source reportedE17
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:committee_appointment:37

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerChristopher A. Viehbacher, President and Chief Executive Officer
Source reportedE5
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:leadership_role:11
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Index MembershipS&P 500 (SPX)
Source reportedE18
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:index_membership:38
Security ListingBIIB (NASDAQ)
Source reportedE1
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:security_listing:39
Index memberships1 membership attached to a specific security and listing.Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.
SPX
Source reportedAs of Oct 24, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
IndexSecurityStatusEffectiveVerificationSource
S&P 500 (S&P Dow Jones Indices)NASDAQ: BIIBcurrentNov 13, 2003inferredSlickcharts S&P 500 constituent table (public observation, not S&P DJI license)

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameBIOGEN INC.
Source reportedE1
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:entity_status:3
Official Websitehttps://www.biogen.com
Source reportedE2
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:official_website:4
Published FactHealthcare
Source reportedE1
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:published_fact:7
Published Facthttps://www.biogen.com
Source reportedE2
company:a2b92c4d-4ab5-4d97-bea2-91da927acb21:published_fact:8

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
18 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 24, 2026. Cited by 6 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    BIOGEN INC. Form 10-K (filed 2026-02-06)
    BIOGEN INC. Form 10-K (filed 2026-02-06). SEC filing. Retrieved Aug 29, 2026. Cited by 2 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    BIIB 10-K executive officers
    sec filing. Published Feb 6, 2026. Retrieved May 13, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    BIIB executive roster source
    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    BIOGEN INC. DEF 14A 2026-04-28
    sec proxy. Published Apr 28, 2026. Retrieved Apr 28, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    BIIB executive roster source
    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
  7. E7
    BIIB 10-K executive officers
    sec filing. Published Feb 6, 2026. Retrieved May 13, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  8. E8
    BIIB 10-K executive officers
    sec filing. Published Feb 6, 2026. Retrieved May 13, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  9. E9
    BIIB executive roster source
    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
  10. E10
    BIIB 10-K executive officers
    sec filing. Published Feb 6, 2026. Retrieved May 13, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  11. E11
    BIIB 10-K executive officers
    sec filing. Published Feb 6, 2026. Retrieved May 13, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  12. E12
    BIIB executive roster source
    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
  13. E13
    BIIB 10-K executive officers
    sec filing. Published Feb 6, 2026. Retrieved May 13, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  14. E14
    BIIB 10-K executive officers
    sec filing. Published Feb 6, 2026. Retrieved May 13, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  15. E15
    BIIB 10-K executive officers
    sec filing. Published Feb 6, 2026. Retrieved May 13, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  16. E16
    BIIB 10-K executive officers
    sec filing. Published Feb 6, 2026. Retrieved May 13, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  17. E17
    Audit
    board_seats. board seats. Cited by 15 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  18. E18
    S&P 500
    Slickcharts S&P 500 constituent table (public observation, not S&P DJI license). index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 24, 2026
  • Adam Keeney executive of Biogen, effective 2026-02-06.
  • Ginger Gregory executive of Biogen, effective 2026-02-06.
  • Jane Grogan executive of Biogen, effective 2026-02-06.
  • Nicole Murphy executive of Biogen, effective 2026-02-06.
  • Priya Singhal executive of Biogen, effective 2026-02-06.
  • Rachid Izzar executive of Biogen, effective 2026-02-06.
  • Ronald J. Kramer executive of Biogen, effective 2026-02-06.
  • Sean Godbout executive of Biogen, effective 2026-02-06.
  • Susan H. Alexander executive of Biogen, effective 2026-02-06.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:a2b92c4d-4ab5-4d97-bea2-91da927acb21, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/biogen-inc

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership14
  4. Board9
  5. Committees3
  6. Control and voting0
  7. Authority to act4
  8. Financials2
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims7
  15. Coverage gaps16
  16. Linked people23
  17. Subject and corrections6
  18. Evidence18
  19. Version historyvpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:a2b92c4d-4ab5-4d97-bea2-91da927acb21
  • Cite this recordBiogen
  • Copy canonical URLregistry.alpha.ac/companies/biogen-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    BiogenCompany
  • Adam KeeneyPerson
  • Ginger GregoryPerson
  • Jane GroganPerson
  • Nicole MurphyPerson
  • Priya SinghalPerson
  • Rachid IzzarPerson
  • Ronald J. KramerPerson
  • Sean GodboutPerson
  • Susan H. AlexanderPerson
  • Andrs Conesa Ph.DPerson
  • Christopher A. ViehbacherPerson
  • George Mclean Milne Jr., Ph.D.Person
  • Jane Grogan, Ph.D.Person
  • Priya Singhal, M.D., M.P.H.Person
  • Eric K. RowinskyPerson
  • Jesus B. MantasPerson
  • Lloyd MinorPerson
  • Maria C. FreirePerson
  • Menelas PangalosPerson
  • Monish PatolawalaPerson
  • Stephen A. SherwinPerson
  • Susan K. LangerPerson
  • William A. HawkinsPerson
  • Sections
    OverviewBiogen
  • MonitoringBiogen
  • LeadershipBiogen
  • BoardBiogen
  • CommitteesBiogen
  • Control and votingBiogen
  • Authority to actBiogen
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.